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1. Introduction 
The number of Kidney transplants has increased in last decades for many advances in 
diagnostic and therapeutic reasons. Kidney transplantation results in superior life 
expectancy and better quality of life if compared to dialysis treatment for patients with end-
stage renal failure. The success of graft survival after kidney transplantation is closely 
associated with early graft function based on intraoperative perfusion characteristics of the 
allograft and good urine output. Clinicians must carefully adjust intravascular volume and 
arterial blood pressure to effectively perfuse the graft, and the time course of volume 
expansion seems important for adequate hydration. The ultimate goal for any renal 
transplantation patient is to have an optimally functioning graft as early as possible after 
completion of surgery. Key strategies that are used to achieve this goal involve the optimal 
management of the intravascular volume and achievement of early urine output. One of the 
reasons for graft failure after renal transplantation is inadequate graft perfusion caused by 
mis-management of perioperative hydration policy. 
2. Chronic renal failure pathophysiology 
Knowledge of the pathophysiologic consequences of chronic renal failure is too important for 
anesthesiologists, because many of these patients have at least one of these sequences, most 
commonly hypertension, coronary artery diseases, diabetes mellitus and pulmonary 
dysfunction. Additionally, disturbance in acid-base, electrolytes and fluid balance are usually 
related to a marked decline in the glomerular filtration rate (GFR) caused by a variety of 
systemic diseases such as diabetes mellitus or hypertension, and renal disorders as chronic 
glomerulonephritis ,cystic kidney disorder ,interstitial nephritis , obstructive uropathy, and 
lupus nephritis. It is essential to recognize the etiology, because the physician should control 
the problem and does not rely on the patients’ ability to comply with the treatment. 
3. Pre-operative Kidney recipient assessment 
The practice of anesthesia for kidney transplant requires a thorough understanding of the 
metabolic and systemic abnormalities in end stage renal disease, familiarity with transplant 
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medicine and expertise in managing and optimizing these patients for the best possible 
outcome. 
Patients undergoing renal transplant surgery possess several risk characteristics like 
cardiovascular diseases, hypertension, diabetes mellitus, and the problems of dialysis. 
Therefore a thorough pre-operative assessment is crucial for successful intra- and 
postoperative management. The preoperative work-up includes Past- medical history, 
dialysis evaluation (How long? How often? When was the last dialysis? ), serum electrolytes 
(serum potassium),  ECG,  chest X-ray and cardiac echocardiography. Dialysis is usually 
indicated within 24-48 hrs before the operation. Overzealous ultra filtration is best avoided. 
Volume status is roughly estimated by their dry weight. Decline of more than 2-4 kg during 
dialysis suggests significant intravascular depletion. Therefore it was advisable to restrict 
fluid removal during preoperative dialysis to a target of 1-2 kg above the formal dry weight. 
(Schnuelle and Johannes Van der Woude: 2006). Antihypertensive drugs and cardiovascular 
medications should be continued until the day of surgery. 
4. Intra-operative hydration policy 
The primary goal of fluid administration is to ensure stable hemodynamics by rapidly 
restoration the circulating plasma volume. However, excessive fluid accumulation, 
particularly in the interstitial tissue should be avoided. The intra-operative hydration 
strategy of both kidney donor and recipient are of paramount important for the insurance 
the success of kidney transplantation and ensure good function of the graft after surgery. 
4.1 Kidney donors hydration policy 
Othman and his colleagues (2010) described in their study the hydration regimen of their 
living kidney donors. The kidney donors, in this study, had received 1500 mls normal saline 
and 1500 mls Ringer's lactate solution, supplemented by crystalloid titrated to match the 
urine output from the start of the surgery until the renal vessels were clamped. Kidney 
donors also received 40 mg furosemide and 150 mL mannitol 10% before nephrectomy.  
To maintain good diuresis, fluid administration for kidney donors is usually generous (10-
20 ml/kg/hr) using isotonic crystalloids during the intra-operative time (Baxi et al 2009). 
However, some centers recommend overnight preoperative hydration with intravenous 
fluids and preloading the patients with colloids just before induction of anesthesia. Good 
hydration of the donor in addition of good hemodynamic intraoperative stability are 
essential requirements for the graft to tolerate ischemia time  after nephrectomy with less 
harm till vascular anastomosis being completed.  
In our center, the harvested kidney in living kidney donor was usually submerged 
immediately in iced Ringer's lactate solution, and the renal artery was flushed with 250 to 
300 mls cold Ringer's lactate solution (4°C) mixed with papaverine 120 mg, heparin 5000 IU, 
and verapamil 10 mg until the venous effluent was clear (Othman et al, 2010).. 
4.2 Kidney recipient hydration policy 
Proper peri-operative fluid management is one of the most important aspects governing 
hemodynamic function in the surgical patient. Adequate hydration is an integral part of the 
anesthetic management during renal transplant. Adequate plasma volume is essential in 
maintaining cardiac output and hence tissue perfusion. The stable hemodynamic status of 
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the recipient during kidney transplant surgery is usually associated with an initial good 
graft function. To decrease the incidence of postoperative acute tubular necrosis (ATN), a 
liberal hydration policy is usually employed intra-operatively. The systolic blood pressure is 
maintained between 130 and 160 mm Hg, and the CVP is maintained between 12 and 14 mm 
Hg (Ferris et al, 2003). Maintaining adequate CVP is especially important in pediatric 
recipients because reperfusion of an adult kidney graft after completion of anastomosis may 
divert a significant amount of cardiac output. Measuring the central venous pressure (CVP) 
is really an absolute requirement to ensure good plasma volume expansion. The pulmonary 
artery pressure also can be used to guide fluid therapy in patients with preoperative left 
ventricular dysfunction (Carlier et al ,1982). Additionally, mean arterial pressure (MAP) less 
than 100 mmHg and plasma volume below 45 mL/kg at reperfusion of the graft are the 
usual risk factors for graft failure (Toth et al ,1998). Blood flow to the allograft after 
reperfusion may predict its immediate function. The early graft function requires adequate 
perfusion that can be achieved by expansion of the intravascular volume of the recipients. 
Recently, a study was designed to examine the time of maximum volume expansion relative 
to renal ischemia period in living-related recipients and its effect on graft perfusion and 
early renal function (Othman et al, 2010). The kidney recipients were randomly assigned in 
this study into to one of two hydration regimens. The hydration regimens that used were 
either the constant infusion rate (CIR) regimen or the CVP target (CVPT) regimen. The CIR 
group received normal saline at a constant infusion rate of a range 10 to 12 ml.kg-1.-1h from 
the start of surgery until the renal vessels were unclamped at the end of anastomosis. 
Isotonic saline 0.9% was infused using a volumetric infusion pump. The CVPT group 
received normal saline at two different CVPT phases. The first “pre-ischemia” phase was 
from the start of surgery until the renal artery in the donor kidney was clamped. During this 
time, saline was infused slowly to maintain the CVP at target within 5 mmHg. In the second 
“ischemia” phase, from clamping the donor renal artery until unclamping of the recipient 
renal artery after vascular anastomosis completion, normal saline was infused to maintain a 
CVPT of around 15 mm Hg. Systolic, diastolic, mean arterial blood pressure, and CVP 
values were recorded 30 minutes after induction of anesthesia, at the time of renal artery 
clamping in the donor (onset of ischemia), at unclamping of the vessels after completion of 
the vascular anastomosis (end of ischemia), and at the end of surgery. Also renal ischemia 
time, concurrent saline infusion rate, time of onset of urine production on unclamping of the 
renal artery, and total urine output from unclamping of the renal vessels to the end of the 
surgery were recorded. Kidney turgidity was evaluated blindly by the surgical team 
members on a 3-point scale: score I (soft graft), score II (moderately turgid graft), and score 
III (highly turgid and firm graft).After surgery, all patients were assessed for the presence of 
tissue edema, especially in the conjunctiva, eyelids, face, and upper airway. Postoperative 
graft function was evaluated by estimation of fraction extraction sodium ratio (FENa %) 
after surgery to assess renal concentrating power: Daily serum creatinine, creatinine 
clearance, and total urine output were recorded for five days postoperatively. Patients in the 
CVPT group showed better intraoperative graft turgidity, arterial blood pressure stability, 
earlier diuresis, and rapid improvement of postoperative graft function. This was achieved 
in the CVPT group without an overall increase in infused saline volume (ranged 3 liters), 
vasopressor use, and diuretic doses compared with the CIR. The biphasic hydration regimen 
applied in the CVPT group with delayed most of the crystalloid administration until shortly 
before the renal vessels were unclamped (with a calculated range of 45-50 ml/min during 
ischemia time) had more favorable outcome. 
www.intechopen.com
 Understanding the Complexities of Kidney Transplantation 
 
262 
Hypotension may occur after unclamping the renal vessels and reperfusion of the graft. It is 
important to maintain the blood pressure because renal function is critically dependent on 
adequate perfusion. The two main factors that may precipitate to immediate 
revascularization hypotension:  
1. Sudden shift of 25% of cardiac output to the renal graft.  
2. Release of vasodilator mediators accumulated during renal ischemia period. 
It is critical that the patient is adequately hydrated throughout renal transplant surgery in 
preparation for reperfusion of the graft. Close monitoring of the CVP, and avoidance of 
deep level of anesthesia during this period can prevent hypotension. The use of 
vasopressors with  agonist action may comprise blood flow to the transplanted organ. 
Additional fluid may be required to maintain blood pressure and replace urine output. 
Furosemide can enhance urine output. Loop diuretics block the Na/K channels in the thin 
ascending loop of Henle. This prevents reabsorption of electrolytes in this part of the 
nephron. The high osmolar fluid then prevents reabsorption of water in the distal tubule. A 
large volume of fluid with high electrolyte content is excreted. Mannitol is freely filtered in 
the glomerulus, but not reabsorbed. It causes osmotic expansion of urine volume.  Loop 
diuretics and /or mannitol may be used to promote diuresis from the grafted kidney. 
Mannitol improves renal blood flow, acts as a free radical scavenger and reduces the 
incidence of impaired renal function immediately after transplant (Kasper et al, 2005). 
Another study was previously done for pediatric kidney recepients used average 
introperative fluids 88 ml/kg with a wide range of 30-90 ml/kg which reflected a large 
range of preoperative hydration status of recipients. However, younger children received 
higher volume of fluids per kilogram than older one. Also this study indicated that there 
was no correlation between the amount of fluid given intraoperatively and the occurrence of 
postoperative oliguria or acute tubular necrosis. (Coupe et al 2005).However, the 
intraoperative fluid replacement during kidney transplantation should be carefully titrated 
to the needs and overload must be avoided to get ride the problems that may developed if 
the new graft is either delayed to function or failing. 
5. The choice of recipient fluid therapy 
The choice of a particular solution in a given clinical situation may be guided by an 
understanding of the solutions’ properties, but there is still an ongoing debate on the 
relative merits of crystalloid and colloid solutions for kidney recipients .The intravenous 
administration of adequate volumes of fluid is associated with earlier onset of graft 
function, lower postoperative serum creatinine, higher postoperative creatinine clearance, 
reduced incidence of delayed graft function, and improved graft survival. Most 
anesthesiologists avoid potassium-containing fluids during renal transplantation with the 
belief that it may worsen hyperkalemia in case of impaired graft function. The 
administration of normal saline and normal saline-based fluids (5% albumin) is the standard 
of care for fluid management in patients undergoing renal transplant surgery. This policy is 
primarily based on avoidance of potassium-containing fluids that can contribute to intra-
operative hyperkalemia. The recipient's blood is usually typed and screened preoperatively. 
However, blood loss is usually minimal during uncomplicated kidney transplantation. Also 
blood transfusion is unlikely practice for kidney recipients except in highly indicated cases 
because of high possibility of triggering the patient's immune system. The anesthesiologist 
should attempt to maintain a mean blood pressure range of 60 to 80 mm Hg, central venous 
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pressure (CVP) between 10 to 14 cm H20 and mean pulmonary artery pressure of 18 to 20 
mm Hg. The estimated blood loss during the case is usually minimal (< 300 ml). In some 
cases, greater blood loss may require transfusion of packed red cells. Packed red cells should 
be cytomegalovirus (CMV) negative. 
5.1 Crystalloids 
Crystalloids solutions are usually preferred during kidney transplantation to correct fluid 
and electrolyte imbalance (Table 1). However in certain situation as in severe hypovolemia, 
colloids may be valuable. A great source of controversy and debate is the choice of intra-
operative fluid during kidney transplantation. In a survey conducted in over 90% of renal 
transplant centers in USA, normal saline was used for hydration during kidney 
transplantation (O'Malley et al 2002). Many studies have shown that the use of normal saline 
leads to a major increase in serum potassium compared with Ringer’s lactate, most likely 
due to associated hyperchloremic metabolic acidosis through an extra cellular shift of 
potassium (O'Malley et al, 2005; Khajavi et al, 2008).  
 
Additives 
(bicarbonate) 
Mg++ 
mMole/l 
Ca++ 
mMole/l 
K+ 
mMole/l 
Cl- 
mMole/l 
+Na 
mMole/l 
 
- - - - 154 154 
Normal Saline  
(0.9%) 
Lactate(28) - 1.5 4 109 130 
Lactated 
Ringer's 
Acetate(28) - 1.5 4 109 130 
Acetated 
Ringer's 
Acetate (27) + 
Gluconate(23) 
3 1.5 5 98 140 Plasmalyte 
Table 1. Commonly used   crystalloids and their composition: 
Hyperchloremia may have adverse renal effects through vasoconstriction in afferent and 
efferent arteriolar beds of kidney and may result in a decrease in the urine output (Wilcox, 
1983). Consequently, the use of Ringer’s lactate is now preferred in renal transplant surgery. It 
is essential to acknowledge that intravenous fluids are behaved like drugs with indications, 
contraindications, and side effects. With this in mind, the anesthetist must carefully choose the 
type of fluid for intra-operative use during kidney transplantation .This choice is based on 
number of factors. These factors include the physical properties of the solution, the patient's 
biochemical profile with special reference of serum electrolytes and surgical circumstances. 
The principal component of crystalloid fluids is the inorganic salt sodium chloride (NaCl). 
Sodium is the most abundant solute in the extracellular fluids, and it is distributed 
uniformly throughout the extracellular space. Because 75 to 80% of the extracellular fluids 
are located in the extravascular (interstitial) space, a similar proportion of the total body 
sodium is in the interstitial fluids. Exogenously administered sodium follows the same 
distribution, so 75 to 80% of the volume of sodium-based intravenous fluids are distributed 
in the interstitial space.This means that the predominant effect of volume resuscitation with 
crystalloid fluids is to expand the interstitial volume rather than the plasma volume. An 
infusion of 1 L of 0.9% sodium chloride (isotonic saline) adds 275 mL to the plasma volume 
and 825 mL to the interstitial volume. Note that the total volume expansion (1100 mL) is 
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slightly greater than the infused volume. This is the result of a fluid shift from the 
intracellular to extracellular space, which occurs because isotonic saline is actually 
hypertonic to the extracellular fluids. 
5.1.1 Isotonic (normal)Saline 
The prototype crystalloid fluid is 0.9% sodium chloride (NaCl), also called isotonic saline 
(osmolarity=308 mOsmole/l) or normal saline. The latter term is inappropriate because a one 
normal (1 N) NaCl solution contains 58 g NaCl per liter (the combined molecular weights of 
sodium and chloride), whereas isotonic (0.9%) NaCl contains only 9 g NaCl per liter. The pH 
of isotonic saline (pH=5.7)is also considerably lower than the plasma pH. These differences are 
rarely of any clinical significance. The chloride content of isotonic saline is particularly high 
relative to that of plasma (154 mEq/L versus 103 mEq/L, respectively), so hyperchloremic 
metabolic acidosis is a potential risk with large-volume isotonic saline infusion.  
5.1.2 Lactated Ringer's 
Ringer’s solution was introduced in 1880 by Sydney Ringer, a British physician and research 
investigator who studied mechanisms of cardiac contraction. The solution was designed to 
promote the contraction of isolated frog hearts, and contained calcium and potassium in a 
sodium chloride diluent. In the 1930s, an American pediatrician named Alexis Hartmann 
proposed the addition of sodium lactate buffer to Ringer’s solution for the treatment of 
metabolic acidoses. The lactated Ringer’s solution, also known as Hartmann’s solution, 
gradually gained in popularity and eventually replaced the standard Ringer’s solution for 
routine intravenous therapy. 
Lactated Ringer’s solution contains potassium and calcium in concentrations that 
approximate the free (ionic) concentrations in plasma. The addition of these cations requires 
a reduction in sodium concentration for electrical neutrality, so lactated Ringer’s solution 
has less sodium than isotonic saline. The addition of lactate (28 mEq/L) similarly requires a 
reduction in chloride concentration and has pH approximate 6.7. The chloride in lactated 
Ringer’s is more closely approximates plasma chloride levels than does isotonic saline. 
Lactated Ringer's is also not an ideal crystalloid.The calcium in lactated Ringer’s can bind to 
certain drugs and reduce their bioavailability and efficacy.Also,lactated Ringer's is 
considered a moderately hypotonic (Osmolarity=273 mOsmaole/l) crystalloid solution. So, 
many studies recommend limited use of lactated Ringer's in patients who at risk of cerebral 
edema (Feldman et al; 1995). 
5.1.3 Acetated Ringer's 
Acetated Ringer's isolution is similar in its compostion to lactated ringer's except 
replacement the lactate with acetate which could converted to bicarbonate in all body cells 
including muscles(Hahn &Drobin, 2003). 
5.1.4  Plasmalyte (Normosl) 
Plasmalyte is a balanced salt solution having electrolyte compostion and osmolarity (294 
mOsmole/l) similar to that of plasma.The major feature of these solutions is the added 
buffer capacity, which gives them a pH that is equivalent to that of plasma (pH=7.4). 
Acetate and gluconate content act as precursors of bicarbonate. This converstion occur 
predominantly in the liver,although acetate could be converted to bicarbonate in other body 
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tissues resulting in less acidosis.An additional feature is the addition of magnesium, which 
may provide some benefit in light of the high incidence of magnesium depletion in 
hospitalized patients .A previous relevant study, which compared different crystalloid 
solutions on acid-base balance and early kidney functions after kidney transplantation,have 
concluded that plasmalyte has the best metabolic profile ( Hadimioglu et al, 2008).  
5.2 Colloids 
Natural available colloid as human albumin has been widely applied for the treatment of 
hypovolemia in critically ill and surgical patients during the last two decades. Albumin is 
being widely replaced by many synthetic colloids such as dextrans, gelatins, and hetastarch 
(HES) solutions. Colloids are stayed in the intravascular compartment because of their 
macromolecules composition. The degree of plasma volume expansion exerted by colloids is 
determined by their concentration, molecular weight, chemical structure, colloid osmotic 
pressure, metabolism, and elimination rate. HES solutions have varying effects on coagulation 
characteristics, which depend on the size of the HES molecules and the degree of hydroxethyl 
substitution. Impaired platelet function, and impaired coagulation profile as measured by 
thromboelastography have been reported to arise during the administration of HES. This 
raises some concern for end stage renal patients undergoing kidney transplantation, because 
they are prone to bleeding complications because of associated platelet dysfunction (Boccardo 
et al; 2004). Although it is rare, severe and life-threatening anaphylactic reactions have been 
reported in association with any of the commonly used semi-synthetic colloids and with 
albumin. The incidence of severe anaphylactic reactions is probably more frequent for gelatins 
(0.35%) and for dextrans (0.27%) than for albumin (0.10%) or for starches (0.06%) This required 
to be considered when weighing the risks/benefits for the use of different plasma volume 
expanders (Laxenaire et al ;1994). A study with a large series of renal transplants from 
deceased donors, revealed a statistically significant benefit from the usage of albumin, though 
mannitol, furosemide, and electrolyte solutions were administered concomitantly ( Dawidson 
et al;1992). Protective properties to the intra-operative administration of mannitol during the 
vascular phase were attributed to the osmotic diuretic and the antioxidant properties of sugar 
alcohols substances. Two of the synthetic colloids that have widely replaced albumin in 
clinical practice – dextrans and gelatins – do not seem on the whole to be preferable to 
albumin. An old comparative study comparing intra-operative albumin and dextran-40 in 
renal transplant recipients from a living related donor did not show any significant difference 
between the two regimens with regards to urine volume output and serial serum creatinine 
concentrations after transplantation (Dawidson et al; 1987). The clinical value of this study 
may be limited, because small sample size (17 patients) had no enough statistical power to 
detect outcome differences. Dextran solutions have been associated with major side-effects, 
such as coagulation disorders, severe anaphylactic reaction, and acute tubular necrosis .This 
has led to major limitation for their usage as plasma volume expansion in kidney 
transplantation (Bergman et al; 1990). 
Hetastarch (HES) solutions (table 2) are originally synthesized from natural polymers of 
amylopectin. The pharmacokinetics of HES solutions depend on their molecular weight and 
C2/C6 hydroxyethylation ratio which influences their degradation mainly by plasma 
amylase. Osmotic, nephrosis-like lesions were reported in 80% of transplanted kidneys after 
the use of routine volumes of HES 200/0.6 in brain-dead donors (Legendre et al ,1993) . The 
likely mechanism for this action may be swelling and vacuolization of the tubular cells, and 
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tubular obstruction due to hyper-viscous urine. Additionally, the slow degradation of high 
molecular weight or highly substituted HES may increase plasma osmotic pressure, leading 
to renal dysfunction and therefore these factors limit their use during kidney 
transplantation. The latest HES generation, HES 130/0.4, has a total body clearance about 
23–31 times faster than that of the first generation hetastarch, and exhibits the best 
risk/benefit ratio of all available HES (Jungheinrich, and Neff ,2005). 
 
  
HES 
70/0.5 
HES 
130/0.4 
HES 
200/0.5 
HES 
200/0.5 
HES 
200/0.62 
HES 
450/0.7 
Concentration 
(%) 
 6 6 6 10 6 6 
Volume 
efficacy (%) 
 100 100 100 130 100 100 
Volume effect 
(hours) 
 1-2 2-3 3-4 3-4 5-6 5-6 
Mean   
molecular 
weight  (KD) 
 70 130 200 200 200 450 
Molar  
substitution 
 0.5 0.4 0.5 0.5 0.62 0.7 
C2/C6 ratio  4:1 9:1 6:1 6:1 9:1 4.6:1 
Table 2. Characteristics of different available hydroxyethyl starch (HES) solutions. 
HES preparations (table 2) are characterized by the following criteria: 
(A) Concentration (6%, 10%), 
(B) Molecular weight (Mw: the sum of each molecule‘s weight devided by the total 
mixture’s weight times the weight of the molecule): 
 Low-molecular weight [LMW]-HES:  70,000 dalton. 
 Medium-molecular weight [MMW]-HES: 130,000  to 260,000 dalton. 
 High-molecular weight [HMW]-HES: > 450,000 dalton, 
(C) Molar substitution (MS: the molar ratio of the total number of hydroxyethyl groups to 
the total number of glucose units): 
 Low MS: 0.4 and 0.5        
 Moderate MS: 0.62              
 High MS: 0.7 
(D) C2/C6 ratio. The ratio of the C2:C6 hydroxyethylation appears to be key factors for 
pharmcokinetic behaviour of HES and possibly also for its side effects (e.g. accumulation). 
However, there still some debates surrounding the effects of hetastarch solutions on renal 
function, especially in the field of kidney transplantation. 
Over the last few decades, there has been a shift in anesthesia practice from using natural 
colloids such as blood, albumin and fresh frozen plasma to synthetic colloids .However, the 
widespread use of synthetic colloids during kidney transplantation is still need more 
investigations to confirm their safety.  
The evidence for Targeted Fluid Administration suggests that administration of colloid 
provides benefits over crystalloids. However no head-to-head trials of crystalloid versus 
colloid or colloid versus colloid during kidney transplantation have been performed. 
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Likewise all the clinical trials of Targeted Fluid Administration used are saline-based fluids. 
A new controversy surrounds the adequate amount of peri-operative fluid administration. 
For decades the strategy has been to keep the patient normovolaemic (‘well hydrated’) in 
the perioperative period. Early urine production is important in kidney transplantation as a 
good prognostic factor. It is usually associated with longer graft survival and lower 
morbidity. Early diuresis is commonly observed in live donor grafts. In dead donor grafts, 
onset of diuresis is usually delayed due to the variable period of kidney ischemia and their 
storage at low temperatures in electrolyte solutions until they are implanted. Some 
measures, such as the administration of large volumes of liquids and diuretics, have been 
advocated to obtain good diuresis at the end of the surgery. Mannitol induces osmotic 
diuresis and also has a protective effect on the tubular cells of transplanted kidney from 
ishaemic injury. The renal protective agents as mannitol used during kidney transplantation 
seems to be related to its ability to increase renal blood flow. This presumably is due to the 
result of release of intrarenal vasodilator prostaglandin and atrial naturetic peptide. Also, 
loop diuretics as furosemide act  by blocking  the Na+/K+ ATPase channels present in the 
thin ascending limb of Henle, decreasing tubular oxygen consumption which may offer 
some protection against ischemic injury( Esson and Schrier;2002). 
  Hypotension may occur after unclamping the vessels and reperfusion of the graft. It is 
important that the patient should be well hydrated, as renal function is critically dependent 
on renal perfusion. It is especially important in paediatric recipients because reperfusion of 
an adult size graft may divert a significant amount of their own blood volume. A previous 
study for special fluid strategy in pediatric kidney transplantation, a total mean volume of 
18 ml.kg-1.h-1was infused, which divided to include approximately 8 ml.kg-1.h-1 of 
crystalloid, 7 ml.kg-1.h-1 of fresh frozen plasma, and 2 ml.kg-1.h-1 of washed red blood 
cells( Yamamoto et al 2003). 
Central venous pressure value may decrease around 50% within two hours after 
revascularization despite aggressive fluid management. This decline is similar in recipients 
of both cadaveric and living related kidney donor and the cause may be multi-factorial such 
as redistribution of fluids, changes in vascular permeability or increased nitric oxide levels. 
The use of vaso-pressors ,with alpha agonist activity, are better to be avoided as they can 
compromise blood flow to the transplanted kidney. Loop diuretics, and mannitol may be 
used to enhance urine production. Low dose dopamine was previously used to stimulate 
dopaminergic receptors (DA1) in the kidney vasculature to induce vasodilatation and 
increased urine output. However, the utility of this approach is questioned in a denervated 
kidney, which it may not respond adequately to a low dose of dopamine as normal kidneys do. 
6. Monitoring 
Standard ASA monitors are adequate, although, patients with more advanced co-morbid 
conditions require more extensive monitoring such as continuous arterial blood pressure 
and pulmonary artery monitoring. Routine monitors include noninvasive arterial blood 
pressure, ECG, core temperature, end-tidal carbon dioxide (ETco2), and arterial oxygen 
saturation SpO2. CVP monitoring is required for all patients in order to guide volume 
management and for postoperative vascular access. .Arterial monitoring is reserved for 
small children undergoing anastamosis of the allograft to the great vessels. Older children 
undergoing anastamosis to the iliac vessels do not require arterial monitoring, and in fact it 
should be avoided in order to preserve sites for future arteriovenous fistulae. Swan-Ganz 
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monitoring of pulmonary artery pressures may be necessary in the infrequent patients with 
symptomatic hypertensive cardiomyopathy or with symptomatic cardiac dysfunction. All 
patients have urinary catheters inserted prior to surgery for urine output records. 
Laboratory investigations every 1-2 hours to follow blood hemoglobin ,Hct, serum K+ and 
acid-base status. Those with the severe co-morbid conditions, such as symptomatic coronary 
artery diseases or history of congestive heart failure, should be monitored with a non-
invasive transesophageal echocardiography to monitor cardiac functions.  
7. Postoperative recipient fluid therapy 
Strict monitoring of fluid input and urine output is essential especially in the early 
postoperative period to guide the function of the new graft. A study showed that recipients 
of living donor kidneys lost more serum albumin during surgery than their donors, 
resulting in decreased plasma volume that was associated with reduced post-operative 
urine output. Therefore, it was recommended that administration of postoperative colloids 
administration is necessary to replace the additional loss of albumin during transplant 
surgery (Dawidson et al; 1987). On the first day after successful transplantation, serum 
creatinine concentration is usually related to mean arterial blood pressure. It is decreased in 
patients with mean arterial pressure (MAP) above 100 mmHg, whereas it remained stable in 
patients with MAP of 80–100 mmHg and increased in patients with MAP below 80 mmHg 
(Toth et al ;1998). Post operative daily graft function was evaluated in another recent study 
that compared the CVP target regimen(15 mmHg) with constant infusion regimen(10-12 
ml.kg-1.hour-1) during transplantation (Othman et al; 2010) .It was based on the renal 
concentrating ability, as reflected by the fractional excretion of sodium (FENa% ) for 6 hours 
in  immediate postoperative time. Also, serum creatinine level, creatinine clearance, and 
urine output were monitored daily for 5 days after surgery. This study reflected early 
postoperative faster decrease of serum creatinine with higher creatinine clearance and larger 
urine output in the CVP target group .This finding could attest to the sustained benefit of 
the central venous pressure titration approach over the constant infusion approach. .FENa % 
may be affected by a high diuretic dose that acts by altering the handling of sodium by the 
kidney. In this study, all patients in the constant infusion regimen  group and only 50% of 
patients in the CVPT group had received variable large doses of furosemide, which might 
account for the early decrease of FENa %. Therefore, FENa % may be not useful as a renal 
function test for comparison between the used hydration regimens (Othman et al ; 2010). 
Maintenance of crystalloid hydration during postoperative period must be adjusted 
accordingly to vital signs and urine output.  Replace urine output (ml per ml) with 
crystalloid selected according to graft function and patient serum electrolytes. A rigorous 
postoperative intravenous hydration protocol in renal transplant recipients may protect 
against vascular thrombosis. Delayed graft function is mainly defined as the need for 
dialysis in the first week after transplant. It may result from a collection of various 
detrimental factors such as recipient's age, tissue match and any surgical complications as 
vessel thrombosis or bleeding. One-year graft survival of a first transplant is approximately 
95%; for recipients of non-identical living-related kidneys, it approximates to 90%; for 
recipients of cadaver kidneys, it approximates 80%; and for re-transplanted recipients of 
cadaver kidneys, it is usually less to approximate 70%. Overall, recipient survival of 
approximately 95% during the first post-transplant year can be expected, although 
cardiovascular deaths remains a major concern (Flechner ; 1994). 
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Postoperative fluid management plan for kidney transplantation should be judicious and be 
modified in favor of maintaining just adequate filling pressures to maintain adequate 
intravascular volume and baseline hemodynamics .Additional fluids as per need once urine 
output from the new graft starts to decline guided by CVP and myocardial function and 
avoid overload that  may empress the heart function with the recommendation of dialysis in 
presence of delayed graft function or acute tubular necrosis. 
8. Summary 
Graft viability associated with renal transplantation is a product of the proper managing of the 
kidney donor, the allograft, and the recipient patient. Short- and long-term outcome is 
influenced by perioperative fluid policy. The function of the transplanted kidney seems to be 
optimized if graft perfusion is greatly maximized through good hydration policy with CVP 
target to approximate15 mmHg. A strategy of crystalloid administration to a target central 
venous pressure resulted in better stability of intraoperative blood pressure, less use of 
vasopressors and furosemide. This could induce a faster decrease in serum creatinine towards 
normal vlue. Perioperative close monitoring of recipients and optimization of intravascular 
fluid volume status to maximize graft perfusion are the usual keys for long-term success of 
renal transplants. Crystalloids are usually considered as the first choice and some colloids 
could be used safely as alternatives during the procedure and in early postoperative periods. 
The ideal crystalloid solution seems resemble the plasma composition with special reference to 
electrolyte content .Although, lactated and acetated Ringer's solutions are moderately hypo-
osmolar, isotonic normal saline has high chloride content that could induce hyperchloermic 
acidosis. Both lactate and acetate are considered as precursors of bicarbonate where lactate 
converted to bicarbonate in the liver and acetate converted to bicarbonate in all body tissues 
resulting in less acidosis. A mixture of normal saline with either lactated or acetated Ringer's 
solution may be the preferred crystalloid choice of fluid therapy during kidney 
transplantation. This policy could provide better guidance for perioperative hydration strategy 
during kidney transplantation until best evidence and multi-center guidelines will be 
established based upon more research in this field. 
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